Skip to Main Content

Author Details

Robert J Wechsler-Reya
Sanford Burnham Prebys Medical Discovery Institute
1978
238
56
Prashant Mali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38039965A road map for the treatment of pediatric diffuse midline glioma.Cancer Cell2024
38039965A road map for the treatment of pediatric diffuse midline glioma.Cancer Cell2024
36054558A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.Int J Cancer2023
36264168N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma.Cancer Res2023
36054558A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.Int J Cancer2023
37945900Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.Nat Genet2023
37827699Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors.J Pharmacol Exp Ther2023
37802055Single-cell mapping identifies MSI<sup>+</sup> cells as a common origin for diverse subtypes of pancreatic cancer.Cancer Cell2023
36516489Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group.Neoplasia2023
370855393D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Nat Commun2023
36899402The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas.Acta Neuropathol Commun2023
36627300Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.Nat Commun2023
37802055Single-cell mapping identifies MSI<sup>+</sup> cells as a common origin for diverse subtypes of pancreatic cancer.Cancer Cell2023
37945900Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.Nat Genet2023
37827699Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors.J Pharmacol Exp Ther2023
370855393D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Nat Commun2023
36516489Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group.Neoplasia2023
36899402The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas.Acta Neuropathol Commun2023
36627300Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.Nat Commun2023
36264168N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma.Cancer Res2023
34077540Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.Neuro Oncol2022
36239623Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers.Clin Cancer Res2022
35835937Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression.Commun Biol2022
36167467Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.J Immunother Cancer2022
36219398Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.Cancer Res2022
35680424Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma.Genes Dev2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36267874The long non-coding RNA <i>SPRIGHTLY</i> and its binding partner PTBP1 regulate exon 5 skipping of <i>SMYD3</i> transcripts in group 4 medulloblastomas.Neurooncol Adv2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
35977718Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts.J Proteome Res2022
36473869Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.Nat Commun2022
34077540Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.Neuro Oncol2022
35322202Disruption of GMNC-MCIDAS multiciliogenesis program is critical in choroid plexus carcinoma development.Cell Death Differ2022
34985972Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases.Sci Transl Med2022
35309309Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets.Front Immunol2022
34907396Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.Nat Neurosci2022
34890975Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures.Biomaterials2022
35121998The current landscape of immunotherapy for pediatric brain tumors.Nat Cancer2022
35680424Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma.Genes Dev2022
35835937Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression.Commun Biol2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36473869Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.Nat Commun2022
36239623Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers.Clin Cancer Res2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36267874The long non-coding RNA <i>SPRIGHTLY</i> and its binding partner PTBP1 regulate exon 5 skipping of <i>SMYD3</i> transcripts in group 4 medulloblastomas.Neurooncol Adv2022
36167467Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.J Immunother Cancer2022
35977718Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts.J Proteome Res2022
36219398Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.Cancer Res2022
34890975Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures.Biomaterials2022
35121998The current landscape of immunotherapy for pediatric brain tumors.Nat Cancer2022
  • 1 - 50 of 476

Recommended Authors

12235University of Miami Miller School of Medicine
Career Start Year 2007
Number of shared co-authors 1
University of Oklahoma Health Sciences Center
Career Start Year 2005
Number of shared co-authors 0
Children's Hospital Of Philadelphia
Career Start Year 2004
Number of shared co-authors 6
Rady Children's Hospital San Diego.
Career Start Year 2003
Number of shared co-authors 6
University of Virginia Department of Pathology
Career Start Year 2001
Number of shared co-authors 1
Nepean Hospital
Career Start Year 1999
Number of shared co-authors 0
Medical University of Innsbruck
Career Start Year 1999
Number of shared co-authors 0
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year 1999
Number of shared co-authors 1
Schulich School of Medicine & Dentistry, Western University
Career Start Year 1998
Number of shared co-authors 1
Boston Children's Hospital
Career Start Year 1997
Number of shared co-authors 6
Tokyo Medical University
Career Start Year 1996
Number of shared co-authors 0
Nationwide Children's Hospital
Career Start Year 1996
Number of shared co-authors 1
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 22
Samsung Medical Center, Sungkyunkwan University College of Medicine
Career Start Year 1994
Number of shared co-authors 0
Nova Scotia Health Authority
Career Start Year 1992
Number of shared co-authors 0
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 2
Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University
Career Start Year 1991
Number of shared co-authors 45
Kanazawa Medical Center Kanazawa Japan.
Career Start Year 1990
Number of shared co-authors 0
Rocky Mountain Regional VA Medical Center, CO University of Colorado
Career Start Year 1989
Number of shared co-authors 0
Flinders University Library, Flinders University
Career Start Year 1985
Number of shared co-authors 2
University of Kansas
Career Start Year 1985
Number of shared co-authors 1
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 0
New York University Winthrop Hospital
Career Start Year 1982
Number of shared co-authors 0
University of Wisconsin School of Medicine and Public Health
Career Start Year 1980
Number of shared co-authors 4
MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 38
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 9
Keck School of Medicine, University of Southern California
Career Start Year 1977
Number of shared co-authors 5
Ann and Robert H Lurie Children's Hospital of Chicago
Career Start Year 1976
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 1975
Number of shared co-authors 3
David Geffen School of Medicine at university of california los angeles
Career Start Year 1964
Number of shared co-authors 1

Collaborators

The Hospital for Sick Children
Co-authored papers 30
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 22
Hospital for Sick Children
Co-authored papers 17
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 14
NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 14
St Jude Children's Research Hospital
Co-authored papers 14
NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 14
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 13
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 12
University of California San Diego
Co-authored papers 12
The Hospital for Sick Children
Co-authored papers 12
Cumming School of Medicine, University of Calgary
Co-authored papers 12
University of California san francisco
Co-authored papers 12
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 10
University of Texas MD Anderson Cancer Center Houston
Co-authored papers 10
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 10
Institut Curie, PSL Research University
Co-authored papers 10
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 9
Ontario Institute for Cancer Research
Co-authored papers 9
Dana-Farber Cancer Institute
Co-authored papers 9
The Research Institute of the McGill University Health Centre, McGill University
Co-authored papers 9
Rady Children's Hospital San Diego.
Co-authored papers 9
University of British Columbia
Co-authored papers 9
University of Wollongong
Co-authored papers 9
The Hospital for Sick Children
Co-authored papers 9
The Hospital for Sick Children, University of Toronto
Co-authored papers 8
Co-authored papers 8
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Co-authored papers 8
University of British Columbia
Co-authored papers 8
BioBox Analytics Inc.
Co-authored papers 8